Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …

Abstract Background: COVID-19–related critical illness is associated with an increased risk
of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the …

Simple Summary The aims of this study are:(1) to analyze the risk of vein thrombosis and
pulmonary embolism in patients affected by pneumonia due to Covid-19;(2) to evaluate …

Importance Thrombotic events are commonly reported in critically ill patients with COVID-19.
Limited data exist to guide the intensity of antithrombotic prophylaxis. Objective To evaluate …

Abstract Background Coronavirus disease 2019 (COVID-19) is associated with a
hypercoagulable state. Limited data exist informing the relationship between anticoagulation …

Objectives To determine the effect of therapeutic anticoagulation, with low molecular weight
heparin (LMWH) or unfractionated heparin (UFH, high dose nomogram), compared to …

Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …

Background SARS-CoV-2 infection has noted derangements in coagulation markers along
with significant thrombotic complications. Post-mortem examinations show severe …

Background Since the body of evidence addressing the coagulation derangements caused
by Coronavirus disease (COVID-19) has been constantly growing, we investigated whether …

Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has …